Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2017

14.01.2017

Utility and safety of the SafeSept™ transseptal guidewire for electrophysiology studies with catheter ablation in pediatric and congenital heart disease

verfasst von: Joseph J. Knadler, Jeffrey B. Anderson, Ahmad S. Chaouki, Richard J. Czosek, Chad Connor, Timothy K. Knilans, David S. Spar

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The atrial transseptal procedure is used in catheter ablation of left-sided arrhythmias. Studies in adult patients have shown the SafeSept™ transseptal guidewire (SSTG) to be effective in atrial transseptal procedures. We analyzed our 5-year experience with SSTG use in pediatric and congenital heart disease patients undergoing catheter ablation.

Methods

This is a single-center retrospective analysis of patients undergoing catheter ablation from 2009 to 2014. We identified all procedures where SSTG was used for atrial transseptal or trans-baffle access. Success of transseptal access and complications were recorded and compared to the standard transseptal approach without the SSTG.

Results

One hundred twenty-seven patients underwent 132 attempted atrial transseptal or trans-baffle procedures using SSTG. Median age was 14 (1.2–38) years. Arrhythmia substrates included AV reentrant tachycardia (90.2%), atrial tachycardia (4.5%), ventricular tachycardia (2.3%), and AV nodal reentrant tachycardia (2.3%). Transseptal or trans-baffle access was successful in 96.2% of the SSTG cases compared to 98.9% in the standard transseptal group without SSTG (p = NS). The youngest patient with successful atrial transseptal procedure using SSTG was 4 years old. SSTG was used to successfully cross a surgically created atrial baffle in a patient who had undergone the Mustard procedure. There was one major complication in both groups, 0.8% in the SSTG group compared to the standard transseptal group without SSTG, 1.1% (p = NS). The major complication in the SSTG group occurred when the SSTG crossed the aorta into the coronary artery system and mimicked placement in the left atrial appendage, with subsequent placement of a transseptal sheath into the aorta, requiring sternotomy and surgical intervention.

Conclusions

SSTG is effective for use in atrial transseptal and surgical trans-baffle access in pediatric and congenital heart disease patients. Placement of the SSTG into the pulmonary vein is necessary to avoid major complications, and if not achieved requires additional methods to determine appropriate left atrial placement.
Literatur
1.
Zurück zum Zitat El-Said HG, Ing FF, Grifka RG, Nihill MR, Morris C, Getty-Houswright D, et al. 18-year experience with transseptal procedures through baffles, conduits, and other intra-atrial patches. Catheter Cardiovasc Interv. 2000;50(4):434–9. discussion 440.CrossRefPubMed El-Said HG, Ing FF, Grifka RG, Nihill MR, Morris C, Getty-Houswright D, et al. 18-year experience with transseptal procedures through baffles, conduits, and other intra-atrial patches. Catheter Cardiovasc Interv. 2000;50(4):434–9. discussion 440.CrossRefPubMed
2.
Zurück zum Zitat Perry JC, Boramanand NK, Ing FF. “Transseptal” technique through atrial baffles for 3-dimensional mapping and ablation of atrial tachycardia in patients with d-transposition of the great arteries. J Interv Card Electrophysiol. 2003;9(3):365–9.CrossRefPubMed Perry JC, Boramanand NK, Ing FF. “Transseptal” technique through atrial baffles for 3-dimensional mapping and ablation of atrial tachycardia in patients with d-transposition of the great arteries. J Interv Card Electrophysiol. 2003;9(3):365–9.CrossRefPubMed
3.
Zurück zum Zitat De Ponti R, Cappato R, Curnis A, Della Bella P, Padeletti L, Raviele A, et al. Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol. 2006;47(5):1037–42.CrossRefPubMed De Ponti R, Cappato R, Curnis A, Della Bella P, Padeletti L, Raviele A, et al. Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol. 2006;47(5):1037–42.CrossRefPubMed
4.
Zurück zum Zitat de Asmundis C, Chierchia GB, Sarkozy A, Paparella G, Roos M, Capulzini L, et al. Novel trans-septal approach using a Safe Sept J-shaped guidewire in difficult left atrial access during atrial fibrillation ablation. Europace. 2009;11(5):657–9.CrossRefPubMed de Asmundis C, Chierchia GB, Sarkozy A, Paparella G, Roos M, Capulzini L, et al. Novel trans-septal approach using a Safe Sept J-shaped guidewire in difficult left atrial access during atrial fibrillation ablation. Europace. 2009;11(5):657–9.CrossRefPubMed
5.
Zurück zum Zitat Wadehra V, Buxton AE, Antoniadis AP, McCready JW, Redpath CJ, Segal OR, et al. The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace. 2011;13(10):1401–5.CrossRefPubMed Wadehra V, Buxton AE, Antoniadis AP, McCready JW, Redpath CJ, Segal OR, et al. The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace. 2011;13(10):1401–5.CrossRefPubMed
6.
Zurück zum Zitat Wieczorek M, Hoeltgen R, Akin E, Salili AR. Use of a novel needle wire in patients undergoing transseptal puncture associated with severe septal tenting. J Interv Card Electrophysiol. 2010;27(1):9–13.CrossRefPubMed Wieczorek M, Hoeltgen R, Akin E, Salili AR. Use of a novel needle wire in patients undergoing transseptal puncture associated with severe septal tenting. J Interv Card Electrophysiol. 2010;27(1):9–13.CrossRefPubMed
7.
Zurück zum Zitat Casadonte JR, Wax DF, Gossett JG. Extracardiac Fontan fenestration using the SafeSept transseptal guidewire and snare-controlled diabolo-shaped covered-stent placement. Catheter Cardiovasc Interv. 2015. Casadonte JR, Wax DF, Gossett JG. Extracardiac Fontan fenestration using the SafeSept transseptal guidewire and snare-controlled diabolo-shaped covered-stent placement. Catheter Cardiovasc Interv. 2015.
8.
Zurück zum Zitat von Alvensleben JC, Dick 2nd M, Bradley DJ, LaPage MJ. Transseptal access in pediatric and congenital electrophysiology procedures: defining risk. J Interv Card Electrophysiol. 2014;41(3):273–7.CrossRef von Alvensleben JC, Dick 2nd M, Bradley DJ, LaPage MJ. Transseptal access in pediatric and congenital electrophysiology procedures: defining risk. J Interv Card Electrophysiol. 2014;41(3):273–7.CrossRef
Metadaten
Titel
Utility and safety of the SafeSept™ transseptal guidewire for electrophysiology studies with catheter ablation in pediatric and congenital heart disease
verfasst von
Joseph J. Knadler
Jeffrey B. Anderson
Ahmad S. Chaouki
Richard J. Czosek
Chad Connor
Timothy K. Knilans
David S. Spar
Publikationsdatum
14.01.2017
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2017
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-017-0224-z

Weitere Artikel der Ausgabe 3/2017

Journal of Interventional Cardiac Electrophysiology 3/2017 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.